Connect with us

Marknadsnyheter

UPS releases 2Q 2022 earnings

Published

on

  • Consolidated Revenues of $24.8B, Up 5.7% from Last Year
  • Consolidated Operating Profit of $3.5B, Up 8.5% from Last Year; Up 9.3% on an Adjusted* Basis
  • Diluted EPS of $3.25; Adjusted Diluted EPS Up 7.5% Over Last Year to $3.29
  • Reaffirms Full-Year 2022 Financial Guidance; Raises Targeted Share Repurchases to $3B for 2022

ATLANTA – July 26, 2022 – UPS (NYSE:UPS) today announced second-quarter 2022 consolidated revenues of $24.8 billion, a 5.7% increase over the second quarter of 2021. Consolidated operating profit was $3.5 billion, up 8.5% compared to the second quarter of 2021, and up 9.3% on an adjusted basis. Diluted earnings per share was $3.25 for the quarter; adjusted diluted earnings per share of $3.29 was 7.5% above the same period in 2021.

For the second quarter of 2022, GAAP results included after-tax transformation and other charges of $31 million, or $0.04 per diluted share.

“I want to thank UPSers around the world for delivering outstanding service to our customers,” said Carol Tomé, UPS chief executive officer. “While the external environment is ever changing, our better not bigger strategic framework has fundamentally improved nearly every aspect of our business, enabling greater agility and strong financial performance.”  

U.S. Domestic Segment

2Q 2022 Adjusted2Q 2022 2Q 2021 Adjusted2Q 2021
Revenue $15,459 M $14,402 M
Operating profit $1,829 M $1,855 M $1,567 M $1,675 M
  • Revenue grew 7.3%, driven by an 11.9% increase in revenue per piece.
  • Operating margin was 11.8%; adjusted operating margin was 12.0%.

International Segment

2Q 2022 Adjusted2Q 2022 2Q 2021 Adjusted2Q 2021
Revenue $5,073 M $4,817 M
Operating profit $1,193 M $1,204 M $1,184 M $1,190 M
  • Revenue increased 5.3%, driven by a 14.8% increase in revenue per piece.
  • Operating margin was 23.5%; adjusted operating margin was 23.7%.

Supply Chain Solutions1

2Q 2022 Adjusted2Q 2022 2Q 2021 Adjusted2Q 2021
Revenue $4,234 M $4,205 M
Operating profit $513 M $517 M $507 M $408 M

1 Consists of operating segments that do not meet the criteria of a reportable segment under ASC Topic 280 – Segment Reporting.

  • Revenue increased 0.7%, led by Forwarding and our healthcare business.
  • Operating margin was 12.1%; adjusted operating margin was 12.2%.

2022 Outlook

The company provides guidance on an adjusted (non-GAAP) basis because it is not possible to predict or provide a reconciliation reflecting the impact of future pension adjustments or other unanticipated events, which would be included in reported (GAAP) results and could be material.

For 2022, UPS reaffirms its full-year financial targets:

  • Consolidated revenue of about $102 billion
  • Consolidated adjusted operating margin of approximately 13.7%
  • Adjusted return on invested capital above 30%
  • Capital expenditures of 5.4% of revenue, or approximately $5.5 billion
  • Dividend payments, subject to board approval, of about $5.2 billion

Finally, UPS is raising the amount of targeted share repurchases for 2022, taking the target to $3 billion for the year.

* “Adjusted” amounts are non-GAAP financial measures. See the appendix to this release for a discussion of non-GAAP financial measures, including a reconciliation to the most closely correlated GAAP measure.

Contacts:

UPS Media Relations: 404-828-7123 or pr@ups.com

UPS Investor Relations: 404-828-6059 (option 4) or investor@ups.com

# # #

Conference Call Information

UPS CEO Carol Tomé and CFO Brian Newman will discuss second-quarter results with investors and analysts during a conference call at 8:30 a.m. ET, July 26, 2022. That call will be open to others through a live Webcast. To access the call, go to www.investors.ups.com and click on “Earnings Conference Call.” Additional financial information is included in the detailed financial schedules being posted on www.investors.ups.com under “Quarterly Earnings and Financials” and as filed with the SEC as an exhibit to our Current Report on Form 8-K.

About UPS

UPS (NYSE: UPS) is one of the world’s largest companies, with 2021 revenue of $97.3 billion, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories. Focused on its purpose statement, “Moving our world forward by delivering what matters,” the company’s 534,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. UPS also takes an unwavering stance in support of diversity, equity, and inclusion.  More information can be found at www.ups.com, about.ups.com and www.investors.ups.com.

Forward-Looking Statements

This release and our filings with the Securities and Exchange Commission contain and in the future may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than those of current or historical fact, and all statements accompanied by terms such as “will,” “believe,” “project,” “expect,” “estimate,” “assume,” “intend,” “anticipate,” “target,” “plan,” and similar terms, are intended to be forward-looking statements. Forward-looking statements are made subject to the safe harbor provisions of the federal securities laws pursuant to Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

From time to time, we also include written or oral forward-looking statements in other publicly disclosed materials. Forward-looking statements may relate to our intent, belief, forecasts of, or current expectations about our strategic direction, prospects, future results, or future events; they do not relate strictly to historical or current facts. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any forward-looking statements because such statements speak only as of the date when made and the future, by its very nature, cannot be predicted with certainty.

Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or anticipated results. These risks and uncertainties, include, but are not limited to the impact of: continued uncertainties related to the COVID-19 pandemic on our business and operations, financial performance and liquidity, our customers and suppliers, and on the global economy; changes in general economic conditions, in the U.S. or internationally; industry evolution and significant competition; changes in our relationships with our significant customers; our ability to attract and retain qualified employees; increased or more complex physical or data security requirements, or any data security breach; strikes, work stoppages or slowdowns by our employees; results of negotiations and ratifications of labor contracts; our ability to maintain our brand image and corporate reputation; disruptions to our information technology infrastructure; global climate change; interruptions in or impacts on our business from natural or man-made events or disasters including terrorist attacks, epidemics or pandemics; exposure to changing economic, political and social developments in international markets; our ability to realize the anticipated benefits from acquisitions, dispositions, joint ventures or strategic alliances; changing prices of energy, including gasoline, diesel and jet fuel, or interruptions in supplies of these commodities; changes in exchange rates or interest rates; our ability to accurately forecast our future capital investment needs; significant expenses and funding obligations relating to employee health, retiree health and/or pension benefits; our ability to manage insurance and claims expenses; changes in business strategy, government regulations, or economic or market conditions that may result in impairments of our assets; potential additional U.S. or international tax liabilities; increasingly stringent laws and regulations, including relating to climate change; potential claims or litigation related to labor and employment, personal injury, property damage, business practices, environmental liability and other matters; and other risks discussed in our filings with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K for the year ended December 31, 2021, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, and subsequently filed reports. You should consider the limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements. We do not undertake any obligation to update forward-looking statements to reflect events, circumstances, changes in expectations, or the occurrence of unanticipated events after the date of those statements.

Information, including comparisons to prior periods, may reflect adjusted results. See the appendix for reconciliations of adjusted results and other non-GAAP financial measures.

Reconciliation of GAAP and Non-GAAP Financial Measures

From time to time we supplement the reporting of our financial information determined under generally accepted accounting principles (”GAAP”) with certain non-GAAP financial measures.  These include: ”adjusted” compensation and benefits; operating expenses; earnings before interest, taxes, depreciation and amortization (“EBITDA”); operating profit; operating margin; other income and (expense); income before income taxes; income tax expense; effective tax rate; net income; and earnings per share. We present revenue, revenue per piece and operating profit on a constant currency basis. Additionally, we disclose free cash flow, return on invested capital (“ROIC”) and the ratio of adjusted total debt to adjusted EBITDA.

We believe that these non-GAAP measures provide meaningful information to assist users of our financial statements in more fully understanding our financial results and cash flows and assessing our ongoing performance, because they exclude items that may not be indicative of, or are unrelated to, our underlying operations and may provide a useful baseline for analyzing trends in our underlying

businesses. These non-GAAP measures are used internally by management for business unit operating performance analysis, business unit resource allocation and in connection with incentive compensation award determinations.

Non-GAAP financial measures should be considered in addition to, and not as an alternative for, our

reported results prepared in accordance with GAAP. Our adjusted financial information does not represent a comprehensive basis of accounting. Therefore, our adjusted financial information may not be comparable to similarly titled information reported by other companies.

Transformation and Other Charges

Adjusted EBITDA, operating profit, operating margin, income before income taxes, net income and

earnings per share may exclude the impact of charges related to transformation activities, goodwill and asset impairments, and divestitures. 

Changes in Foreign Currency Exchange Rates and Hedging Activities

Currency-neutral revenue, revenue per piece and operating profit exclude the period over period impact of foreign currency exchange rate changes and any foreign currency hedging activities.  These measures are calculated by dividing current period reported U.S. dollar revenue, revenue per piece and operating profit by the current period average exchange rates to derive current period local currency revenue, revenue per piece and operating profit. The derived amounts are then multiplied by the average foreign exchange rates used to translate the comparable results for each month in the prior year period (including the impact of any foreign currency hedging activities). The difference between the current period reported U.S. dollar revenue, revenue per piece and operating profit and the derived current period U.S. dollar revenue, revenue per piece and operating profit is the period over period impact of foreign currency exchange rates and hedging activities.

Pension and Postretirement Adjustments

We recognize changes in the fair value of plan assets and net actuarial gains and losses in excess of a 10% corridor (defined as 10% of the greater of the fair value of plan assets or the plan’s projected

benefit obligation), as well as gains and losses resulting from plan amendments, for our pension and

postretirement defined benefit plans immediately as part of other pension income (expense). We

supplement the presentation of our income before income taxes, net income and earnings per share with adjusted measures that exclude the impact of these gains and losses and the related income tax effects. We believe excluding these defined benefit plan gains and losses provides important supplemental information by removing the volatility associated with plan amendments and short-term changes in market interest rates, equity values and similar factors.

The deferred income tax effects of pension and postretirement adjustments are calculated by multiplying the statutory tax rates applicable in each tax jurisdiction, including the U.S. federal jurisdiction and various U.S. state and non-U.S. jurisdictions, by the adjustments.

Free Cash Flow

We calculate free cash flow as cash flows from operating activities less capital expenditures, proceeds from disposals of property, plant and equipment, and plus or minus the net changes in finance receivables and other investing activities. We believe free cash flow is an important indicator of how much cash is generated by our ongoing business operations and we use this as a measure of incremental cash available to invest in our business, meet our debt obligations and return cash to shareowners.

Return on Invested Capital

ROIC is calculated as the trailing twelve months (“TTM”) of adjusted operating income divided by the

average of total debt, non-current pension and postretirement benefit obligations and shareowners’

equity, at the current period end and the corresponding period end of the prior year. Because ROIC is not a measure defined by GAAP, we calculate it, in part, using non-GAAP financial measures that we believe are most indicative of our ongoing business performance. We consider ROIC to be a useful measure for evaluating the effectiveness and efficiency of our long-term capital investments.

Adjusted Total Debt / Adjusted EBITDA

Adjusted total debt is defined as our long-term debt and finance leases, including current maturities, plus non-current pension and postretirement benefit obligations. Adjusted EBITDA is defined as earnings before interest, taxes, depreciation and amortization adjusted for restructuring and other costs and investment income and other. We believe the ratio of adjusted total debt to adjusted EBITDA is an important indicator of our financial strength, and is a ratio used by third parties when evaluating the level of our indebtedness.

Forward-Looking Non-GAAP Metrics

From time to time when presenting forward-looking non-GAAP metrics, we are unable to provide quantitative reconciliations to the most closely correlated GAAP measure due to the uncertainty in the timing, amount or nature of any adjustments, which could be material in any period.

Reconciliation of GAAP and Non-GAAP Income Statement Items
(in millions, except per share amounts):

Three Months Ended June 30, 2022
As Reported (GAAP) Transformation & Other Adj.(1) As Adjusted(Non-GAAP)
U.S. Domestic Package $              13,630  $                     26 $              13,604 
International Package                   3,880                         11                    3,869 
Supply Chain Solutions                   3,721                           4                   3,717 
Operating Expense                 21,231                         41                 21,190 
U.S. Domestic Package                   1,829                         26                   1,855 
International Package                   1,193                         11                    1,204 
Supply Chain Solutions                      513                          4                      517
Operating Profit                   3,535                         41                   3,576 
Other Income and (Expense):
Other pension income (expense)                      298                         —                      298
   Investment income (expense) and other                        35                         —                        35
   Interest expense                     (171)                         —                     (171)
Total Other Income (Expense)                      162                         —                      162
Income Before Income Taxes                   3,697                         41                   3,738 
Income Tax Expense                      848                        10                      858
Net Income $                2,849  $                     31 $                2,880 
Basic Earnings Per Share $                  3.26  $                  0.04  $                  3.30 
Diluted Earnings Per Share $                  3.25  $                  0.04  $                  3.29 

(1) Transformation & Other of $41 million reflects other employee benefits costs of $23 million and other costs of $18 million.

Reconciliation of GAAP and Non-GAAP Income Statement Items
(in millions, except per share amounts):

Six Months Ended June 30, 2022
As Reported (GAAP) Pension Adj.(1) Transformation & Other Adj.(2) As Adjusted(Non-GAAP)
U.S. Domestic Package $              27,092  $                      — $                     69 $              27,023 
International Package                   7,640                          —                        15                   7,625 
Supply Chain Solutions                   7,626                          —                        12                   7,614 
Operating Expense                 42,358                          —                        96                 42,262 
U.S. Domestic Package                   3,491                          —                        69                   3,560 
International Package                   2,309                          —                        15                   2,324 
Supply Chain Solutions                      986                         —                        12                      998
Operating Profit                   6,786                          —                        96                   6,882 
Other Income and (Expense):
Other pension income (expense)                      629                       (33)                         —                      596
   Investment income (expense) and other                        19                         —                         —                        19
   Interest expense                     (345)                         —                         —                     (345)
Total Other Income (Expense)                      303                       (33)                         —                      270
Income Before Income Taxes                   7,089                        (33)                        96                   7,152 
Income Tax Expense                   1,578                          (9)                        22                   1,591 
Net Income $                5,511  $                    (24) $                     74 $                5,561 
Basic Earnings Per Share $                  6.31  $                 (0.03) $                  0.08  $                  6.36 
Diluted Earnings Per Share $                  6.28  $                 (0.03) $                  0.08  $                  6.33 

(1)  Represents the impact of curtailment of benefits effective December 31, 2023, for the Canada LTD Retirement Plan.                          

(2) Transformation & Other of $96 million reflects other employee benefits costs of $56 million and other costs of $40 million.

Reconciliation of Currency Adjusted Revenue, Revenue Per Piece,
and Adjusted Operating Profit
(in millions, except per piece amounts)

Three Months Ended June 30,
2022As-Reported(GAAP) 2021As-Reported(GAAP) % Change(GAAP) CurrencyImpact 2022CurrencyNeutral(Non-GAAP)(1) % Change(Non-GAAP)
Average Revenue Per Piece:
International Package:
   Domestic $            7.61 $            7.44 2.3 % $       0.84 $              8.45 13.6  %
   Export             36.91             32.60 13.2  %         1.53               38.44 17.9  %
      Total International Package $          22.17 $          19.32 14.8  % $       1.18 $            23.35 20.9  %
Consolidated $          13.72 $          12.26 11.9  % $       0.18 $            13.90 13.4  %
Revenue:
  U.S. Domestic Package $        15,459  $        14,402  7.3 % $          — $          15,459  7.3 %
  International Package             5,073             4,817 5.3 %          261               5,334 10.7  %
  Supply Chain Solutions(2)             4,234             4,205 0.7 %            62               4,296 2.2 %
  Total revenue $        24,766  $        23,424  5.7 % $        323 $          25,089  7.1 %
2022As-Adjusted(Non-GAAP) 2021As-Adjusted(Non-GAAP) % Change(Non-GAAP) CurrencyImpact 2022As-AdjustedCurrencyNeutral(Non-GAAP)(1) % Change(Non-GAAP)
As-Adjusted Operating Profit(3):
  U.S. Domestic Package $            1,855 $            1,675 10.7  % $          — $             1,855 10.7  %
  International Package               1,204               1,190 1.2 %            60               1,264 6.2 %
  Supply Chain Solutions(2)                  517                  408 26.7  %           (15)                  502 23.0  %
  Total operating profit $            3,576 $            3,273 9.3 % $         45 $             3,621 10.6  %

(1) Amounts adjusted for period over period foreign currency exchange rate and hedging differences

(2) The divestiture of UPS Freight was completed on April 30, 2021.

(3) Amounts adjusted for transformation & other

Reconciliation of Currency Adjusted Revenue, Revenue Per Piece,
and Adjusted Operating Profit
(in millions, except per piece amounts)

Six Months Ended June 30,
2022As-Reported(GAAP) 2021As-Reported(GAAP) % Change(GAAP) CurrencyImpact 2022CurrencyNeutral(Non-GAAP)(1) % Change(Non-GAAP)
Average Revenue Per Piece:
International Package:
   Domestic $            7.48 $            7.38 1.4 % $       0.65 $              8.13 10.2  %
   Export             35.47             31.85 11.4  %         1.14               36.61 14.9  %
      Total International Package $          21.29 $          18.91 12.6  % $       0.89 $            22.18 17.3  %
Consolidated $          13.49 $          12.19 10.7  % $       0.13 $            13.62 11.7  %
Revenue:
  U.S. Domestic Package $        30,583  $        28,412  7.6 % $          — $          30,583  7.6 %
  International Package             9,949             9,424 5.6 %          404             10,353  9.9 %
  Supply Chain Solutions(2)             8,612             8,496 1.4 %            99               8,711  2.5 %
  Total revenue $        49,144  $        46,332  6.1 % $        503 $          49,647  7.2 %
2022As-Adjusted(Non-GAAP) 2021As-Adjusted(Non-GAAP) % Change(Non-GAAP) CurrencyImpact 2022As-AdjustedCurrencyNeutral(Non-GAAP)(1) % Change(Non-GAAP)
As-Adjusted Operating Profit(3):
  U.S. Domestic Package $            3,560 $            3,138 13.4  % $          — $             3,560 13.4  %
  International Package               2,324               2,281 1.9 %            88               2,412 5.7 %
  Supply Chain Solutions(2)                  998                  803 24.3  %           (18)                  980 22.0  %
  Total operating profit $            6,882 $            6,222 10.6  % $         70 $             6,952 11.7  %

(1) Amounts adjusted for period over period foreign currency exchange rate and hedging differences

(2) The divestiture of UPS Freight was completed on April 30, 2021.

(3) Amounts adjusted for transformation & other

Reconciliation of Free Cash Flow (Non-GAAP measure)
(in millions):

Six Months Ended June 30,
2022
Cash flows from operating activities $                            8,293 
Capital expenditures                             (1,388)
Proceeds from disposals of property, plant and equipment                                      9 
Net change in finance receivables                                      7 
Other investing activities                                   (26)
   Free Cash Flow (Non-GAAP measure) $                            6,895 

Reconciliation of Adjusted Debt to Adjusted EBITDA (Non-GAAP measure)
(in millions):

TTM(1)
June 30,
2022
Net income $               10,933 
Add back:
Income tax expense                    3,111 
Interest expense                        695
Depreciation & amortization                    3,018 
EBITDA                  17,757 
Add back (deduct):
Transformation and other                        231
Defined benefit plan (gains) and losses                        (15)
Investment income and other                   (1,151)
Adjusted EBITDA $               16,822 
Debt and finance leases, including current maturities $               20,576 
Add back:
Non-current pension and postretirement benefit obligations                    8,343 
Adjusted total debt $               28,919 
Adjusted total debt/adjusted EBITDA                      1.72 

  (1) Trailing twelve months

Reconciliation of Return on Invested Capital (Non-GAAP measure)
(in millions):

TTM(1)
June 30,
2022
Net income $                      10,933    
Add back (deduct):
Income tax expense 3,111
Interest expense 695
Other pension (income) expense (1,181)
Investment (income) expense and other 15
Operating profit 13,573
Transformation and other 231
Adjusted operating profit $                      13,804    
Average debt and finance leases, including current maturities 21,584
Average non-current pension and postretirement benefit obligations 8,009
Average shareowners’ equity 13,566
Average Invested Capital $                      43,159    
Net income to average invested capital 25.3  %
Adjusted Return on Invested Capital 32.0  %

(1) Trailing twelve months

Shenique Edwards , Kommunikationsansvarig, UPS Storbritannien, Irland och Norden.
e-post: sheniqueedwards@ups.com 
Tel: +44 7816 646050

Om UPS
UPS (NYSE: UPS) är ett av världens största paketleveransföretag med en omsättning på 84,6 miljarder dollar (2020). UPS erbjuder ett brett utbud av integrerade logistiklösningar för kunder i mer än 220 länder och områden världen över. Företaget har över 540 000 anställda och mottot ”Moving our world forward by delivering what matters”, där vi alla arbetar efter strategin: Customer First. People Led. Innovation Driven. UPS har åtagit sig att minska sin miljöpåverkan och stödja de samhällen vi arbetar för runt om i världen. UPS arbetar även aktivt med mångfald, jämlikhet och inkludering. Företaget finns på ups.com, med mer information på about.ups.com och investors.ups.com/

Taggar:

Continue Reading

Marknadsnyheter

Kinda Brave Entertainment Group AB (publ) publicerar årsredovisning för 2023

Published

on

By

Umeå, 20 april 2024 

Kinda Brave Entertainment Group AB (publ) (“Kinda Brave”) publicerar årsredovisning och revisionsberättelse för 2023 enligt bilaga. 
 
 
För mer information, vänligen kontakta:  

ir@kindabrave.com

www.kindabrave.com

 
 
Följ gärna oss på Linkedin:  

https://www.linkedin.com/company/kinda-brave/

 
 
Om Kinda Brave Entertainment Group AB (publ) 

Kinda Brave är en modern spelkoncern, fokuserat på att förvärva, äga och utveckla spelstudios och immateriella rättigheter, samt utveckla en division inriktad mot förläggning av speltitlar från tredjepart. Idag består Bolaget av fyra spelstudior och ett mindre förläggarteam. Kinda Braves vision är att skapa en unik underhållningsgrupp, med starka immateriella rättigheter inom olika områden, inklusive TV-serier, filmer och serietidningar. 

Continue Reading

Marknadsnyheter

BioArctic och Eisai ingår forskningsutvärderingsavtal avseende BAN2802

Published

on

By

Stockholm, Sverige den 20 april 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) meddelade idag att BioArctic AB och Eisai Co., Ltd., ingått ett samarbetsavtal avseende BAN2802, en potentiell ny behandling som kombinerar BioArctics egenutvecklade BrainTransporter™-teknologi med en läkemedelskandidat mot Alzheimers sjukdom. Vid slutet av samarbetet kommer Eisai att utvärdera den data som genererats och besluta om de vill utnyttja en option att licensiera BAN2802 för behandling av Alzheimers sjukdom.

BioArctic och Eisai har sedan 2005 ett långvarigt samarbete gällande utveckling och kommersialisering av läkemedel för behandling av Alzheimers sjukdom. Samarbetet har lett fram till Leqembi® (lecanemab) – världens första godkända[1] läkemedel som visat sig bromsa utvecklingen av tidig Alzheimers sjukdom. Det nya samarbetet bygger på företagens gemensamma kunskap inom Alzheimers sjukdom. Kostnader för forskningsutvärderingsprogrammet kommer att delas mellan bolagen och programmet kommer att utvärdera vad som skulle kunna bli nästa generations sjukdomsmodifierande behandling för Alzheimers sjukdom.

– Jag är mycket glad över att vår Brain Transporter-teknologi fortsätter att utvecklas väl och att vi nu ingått detta första avtal där denna teknik används. Teknologin har en stor potential att kunna förbättra många olika läkemedelsprojekt och hjälpa företag i deras strävan att utveckla läkemedel mot hjärnans sjukdomar, sa Gunilla Osswald, vd på BioArctic. Eisai har varit en värdefull partner till BioArctic under de senaste två decennierna, och vi är mycket glada över att förlänga och fördjupa vår relation genom detta nya forskningssamarbete med BAN2802. Tillsammans har vi tagit fram lecanemab, den första fullt godkända sjukdomsmodifierande behandlingen vid Alzheimers sjukdom i USA, Japan och Kina och vi ser fram emot att fortsätta vårt givande samarbete och leda utvecklingen av nästa generations läkemedel för att hjälpa patienter med den här förödande sjukdomen.

BioArctics egenutvecklade BrainTransporter-teknologi hjälper till att transportera biologiska läkemedel över blod-hjärnbarriären in i hjärnan. Tekniken har potential att medföra snabbare och starkare effekt av behandlingar riktade till hjärnan, samtidigt som den minskar behandlingsbördan för både patienter och samhället. BrainTransporter-teknologin är en viktig del i BioArctics hållbarhetsarbete och bolagets strävan efter att kontinuerligt förbättra klinisk och kommersiell nytta.

Detta pressmeddelande berör en läkemedelskandidat under utveckling och avser inte att förmedla några slutsatser gällande effekt och säkerhet. Det finns ingen garanti för att denna läkemedelskandidat vare sig kommer att slutföra det kliniska utvecklingsprogrammet eller erhålla godkännande av relevanta myndigheter.

Denna information är sådan information som BioArctic AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades, genom nedanstående kontaktpersons försorg, för offentliggörande den 20 april 2024, kl. 09.40 CET.

För ytterligare information, vänligen kontakta:  
Oskar Bosson, VP Communications and Investor Relations 
E-mail: oskar.bosson@bioarctic.se  
Telefon: +46 70 410 71 80 

Om samarbetet mellan BioArctic och Eisai  
BioArctic har sedan 2005 ett långsiktigt samarbete med Eisai kring utveckling och kommersialisering av läkemedel för behandling av Alzheimers sjukdom. De viktigaste avtalen är utvecklings- och kommersialiseringsavtalet avseende antikroppen lecanemab som ingicks 2007 och utvecklings- och kommersialiseringsavtalet avseende antikroppen Leqembi back-up för Alzheimers sjukdom som ingicks 2015. 2014 ingick Eisai och Biogen ett gemensamt utvecklings- och kommersialiseringsavtal som innefattar lecanemab. Eisai ansvarar för den kliniska utvecklingen, ansökan om marknadsgodkännande och kommersialisering av produkterna för Alzheimers sjukdom. BioArctic har rätt att kommersialisera lecanemab i Norden och för närvarande förbereder Eisai och BioArctic en gemensam kommersialisering i regionen. BioArctic har inga utvecklingskostnader för lecanemab inom Alzheimers sjukdom och har rätt till betalningar i samband med myndighetsgodkännanden och försäljningsmilstolpar samt royalties på den globala försäljningen.  

Om BioArctic AB  
BioArctic AB (publ) är ett svenskt forskningsbaserat biofarmabolag med fokus på innovativa läkemedel som kan fördröja eller stoppa sjukdomsförloppet av neurodegenerativa sjukdomar. Företaget ligger bakom Leqembi® (lecanemab) – världens första läkemedel som bevisat bromsar sjukdomsutvecklingen och minskar den kognitiva försämringen vid tidig Alzheimers sjukdom. Leqembi har utvecklats i samarbete med BioArctics partner Eisai, som ansvarar för kommersialisering och regulatoriska processer globalt. Utöver Leqembi har BioArctic en bred forskningsportfölj med antikroppar mot Parkinsons sjukdom och ALS samt ytterligare projekt mot Alzheimers sjukdom. I flera av projekten används bolagets egenutvecklade teknologiplattfrom BrainTransporter™ som hjälper till att förbättra transporten av antikroppar in i hjärnan. BioArctics B-aktie (BIOA B) är noterad på Nasdaq Stockholm Large Cap. För ytterligare information, besök www.bioarctic.com.

[1] Godkänt i USA, Japan och Kina.

Continue Reading

Marknadsnyheter

Nu lanseras Sevärt, Sveriges minsta kulturkanal

Published

on

By

Statens fastighetsverk, logotyp.

    

Att berätta om de natur- och kulturmiljöer som Statens fastighetsverk (SFV) förvaltar är en viktig del av myndighetsuppdraget. Den 20 april lanseras den nya strömningstjänsten Sevärt, Sveriges minsta kulturkanal, så att hela Sverige ska kunna ta del av berättelserna.

    

Det finns många sevärda platser i SFV:s förvaltning. De är spridda från norr till söder och är – i den mån de går att hålla öppna – ofta välbesökta av dem som bor inom rimliga avstånd. Nu skapas möjligheten för fler att ta del av dessa skatter.

         Våra fastigheter är allas angelägenhet och målet är att de ska engagera ännu fler genom kunskap, spännande berättelser och intagande miljöer, säger generaldirektör Max Elger.

För dem som inte har möjlighet att fysiskt besöka fastigheterna har SFV via bland annat filmer och podd försökt nå ut till fler. Nu förenas resultatet i Sevärt, en öppen playtjänst med strömmat material om SFV:s natur- och kulturmiljöer. Tittarna får följa med in i hantverkares verkstäder, se hemliga rum, uppleva historiska trädgårdar och besöka många andra sevärdheter.

Lanseringen sker den 20 april. Plattformen kommer sedan kontinuerligt att fyllas på med nytt innehåll. Tanken är att Sevärt också ska kunna innehålla material i samarbete med andra aktörer.

Under Stockholms kulturnatt passar Statens fastighetsverk även på att öppna upp ett sevärt, hemligt rum – det gamla vattentornet på Skeppsholmen. Där blir det filmvisning, liveinspelning av podden På plats i historien och popcorn.

För mer information kontakta

Maria Uggla, pressekreterare

010-478 76 00

073-332 22 14

maria.uggla@sfv.se

 

Taggar:

Continue Reading

Trending

Copyright © 2017 Zox News Theme. Theme by MVP Themes, powered by WordPress.